Drug Prices
The Food and Drug Administration released the first phase of its searchable Purple Book database, which includes all FDA-approved biosimilar and interchangeable products.
The House Ways and Means Health Subcommittee held a hearing on proposals to lower drug prices and promote new cures.
The Campaign for Sustainable Rx Pricing launched an ad campaign calling for Congress to pass bipartisan legislation to “hold Big Pharma accountable.”
With rising prices for insulin and the costs of many other diabetes-related drugs taking their toll on patients, CVS Health recently announced that its pharmacy benefits management unit CVS Caremark is launching a program to enable employers and payers to offer these medications at no out-of-pocket…
Tom Nickels, AHA executive vice president, responds to a PhRMA-funded study that attempts to deflect blame for a growing crisis of their own making – the skyrocketing costs of drugs.
The Centers for Medicare & Medicaid Services today updated its Medicare and Medicaid drug spending dashboards with 2018 data.
The pharmaceutical industry’s latest “report” is an obvious attempt to divert attention away from a problem of their own making: skyrocketing drug prices.
Senate Finance Committee leaders Friday released changes to the Prescription Drug Pricing Reduction Act that would eliminate impending Medicaid cuts to disproportionate share hospitals for two years.
The latest report from AIR340B continues to misrepresent a program with a more than 25-year history of helping hospitals stretch scarce financial resources to expand and improve access to lifesaving prescription drugs and comprehensive health services for the many patients served by participating…